Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 59,159 $ 60,698
Short-term investments 130,976 248,933
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 10,810 11,664
Total current assets 201,139 321,489
Property and equipment, net 57,090 68,576
Operating lease assets 14,396 0
Restricted cash - long-term 1,200 1,200
Other assets 319 574
Total assets 274,144 391,839
Current liabilities:    
Accounts payable 6,420 3,719
Accrued compensation 7,822 10,636
Accrued research and development expenses 5,139 19,210
Other current liabilities 6,422 6,414
Total current liabilities 25,803 39,979
Operating lease liabilities - long-term 14,919 0
Other long-term liabilities 1,143 13,003
Total liabilities 41,865 52,982
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of June 30, 2019 and December 31, 2018, respectively; 46,883 and 45,951 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively 5 5
Additional paid-in capital 899,671 866,541
Accumulated other comprehensive income (loss) 173 (340)
Accumulated deficit (667,570) (527,349)
Total stockholders’ equity 232,279 338,857
Total liabilities and stockholders’ equity $ 274,144 $ 391,839